Lung Non Small Cell Carcinoma

AUG 14, 2026 · PHASE 3 TRIAL

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

ClinicalTrials.gov

This is a registered but actively recruiting Phase 3 trial with no results posted; the design is sound but evidence cannot yet be evaluated.

AUG 11, 2026 · PHASE 3 TRIAL

Testing the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients With Non-Small Cell Lung Cancer

ClinicalTrials.gov

This is a Phase 3 trial registration with no results posted; the study is active but not yet recruiting and outcome data are not available.

AUG 10, 2026 · PHASE 3 TRIAL

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

ClinicalTrials.gov

This is a Phase 3 RCT registration with no results posted; the trial is actively recruiting and designed to compare durvalumab against observation in early-stage NSCLC after surgery, but outcome data are not yet available.

AUG 7, 2026 · PHASE 3 TRIAL

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

ClinicalTrials.gov

This is a Phase 3 trial registration with no results posted; the study is still recruiting and has not yet reported outcomes.